Evaluation of the Efficacy of Non-drug Therapy (SMS Intervention) for Adolescents With NSSI
NCT ID: NCT04481425
Last Updated: 2022-11-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
86 participants
INTERVENTIONAL
2020-12-23
2022-01-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of Interventions to Prevent Suicide of Medical Students Through the School-Based Social Support System
NCT00370448
Social Feedback and Dysfunctional Risk Taking in NSSI Adolescents
NCT05981677
Effectiveness Trial of Youth Suicide Prevention Delivered by Teen Peer Leaders
NCT02043093
Mobile Phone Intervention to Reduce Youth Suicide in Rural Communities
NCT03145363
Self-harming Behaviors Study of Adolescents in a Juvenile Detention House
NCT01130441
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
intervention group
Text messages will be sent to the subjects through the investigator, including giving popularization of psychiatric knowledge, coping skills, emotional regulation strategies, and brief care. Two or three times a week for two months.
SMS intervention
SMS intervention
control group
Subjects both collected in the outpatient department and the ward were randomly divided into the control group and regularly followed up.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
SMS intervention
SMS intervention
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Meet the diagnostic criteria of NSSI behavior recommended by DSM-5.
3. The adolescents who have mobile phone, and have the ability to send or receive text messages.
4. Adolescents and guardians agreed to participate and signed the informed consent form
Exclusion Criteria
2. Adolescents with cognitive impairment, neurodevelopmental disorder, mental retardation, visual impairment who cannot complete the study.
3. The adolescents who do not have a mobile phone.
10 Years
19 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Central South University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jian-Jun Ou
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jianjun Ou, doctor
Role: STUDY_CHAIR
Central South University
Runsen Chen, doctor
Role: STUDY_DIRECTOR
Central South University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Psychiatry, Xiangya Second Hospital, Central South University
Changsha, Hunan, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MD20200309
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.